Espínola N, Secco A, Balan D, et al. Budget impact of upadacitinib in patients with moderate to severe rheumatoid arthritis in Argentina. Rev Peru Med Exp Salud Publica. 2024;41(2):129-38. doi:10.17843/rpmesp.2024.412.12934